Shire Human Genetic Therapies is recalling 38,531 units of Natpara (parathyroid hormone) for Injection because the delivery system may be defective. Rubber particles from the cartridge stopper can break off and clog the needle, which may prevent patients from receiving their full intended dose of medication. This recall includes the 25 mcg, 50 mcg, 75 mcg, and 100 mcg dose strengths distributed across the United States. Consumers should contact their healthcare provider or pharmacist immediately for guidance and to discuss alternative treatment options.
Fragments of the rubber stopper can break off during use and clog the injection needle, which leads to the delivery of an incomplete dose of parathyroid hormone. Underdosing of this medication can cause serious health complications related to low calcium levels.
Pharmacy refund and healthcare consultation.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.